What does the term "pharming" refer to in biotechnology?

The term "pharming" specifically refers to the use of genetically modified organisms, particularly plants and animals, to produce pharmaceuticals and other health-related products. This technique harnesses the capabilities of biotechnology to create medications, vaccines, and therapeutic proteins in a more efficient manner compared to traditional methods. By genetically modifying organisms, scientists can improve the yield of desired substances and ensure their effectiveness, which can lead to significant advancements in medical treatments.

In the context of agricultural biotechnology, pharming highlights the intersection of agriculture and pharmaceuticals, showcasing how living organisms can be engineered not just for food production, but also for the production of valuable medicinal compounds. This innovative approach can contribute to more sustainable and cost-effective pharmaceutical manufacturing.

Other options relate to agricultural practices and uses but do not encapsulate the specific definition of pharming in the biotechnology sphere. While they may have their own merits and applications, they do not accurately describe the intersection of genetics and pharmaceutical production that characterizes pharming.